Posted by Michael Wonder on 27 Apr 2023
Two new personalised immunotherapy treatments for aggressive forms of blood cancer recommended for the Cancer Drugs Fund
27 April 2023 - NICE recommends two CAR-T therapies, both given as one-off infusions, to treat aggressive forms of blood cancer
Hundreds of people with aggressive forms of blood cancer are set to benefit after two personalised immunotherapy (CAR-T) treatments were today recommended by NICE for the Cancer Drugs Fund.
